Results
MPS Pharmaa Q2 FY27 Reports Zero Revenue, ₹16.5L Loss
Board approved Q2 FY27 standalone results showing zero operational revenue and a net loss of ₹16.50 lakhs.
Company's drug manufacturing licenses are under renewal with FDA; operations suspended pendin
